Ecological approaches to oral biofilms: Control without killing

Caries Research

Volumn 49, Issue , 2015, Pages 46-54

  Marsh, Phil D ^a,c   Head, David A ^b   Devine, Deirdre A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c PHE Porton   (United Kingdom)

Author keywords

Antimicrobial agents; Biofilm; Modelling; Oral microbiome; Plaque control

Indexed keywords

ANTIINFECTIVE AGENT;

BIOFILM; COMPUTER SIMULATION; DENTAL PLAQUE; DRUG EFFECTS; FEEDING BEHAVIOR; HEALTH; HUMAN; MICROBIAL VIABILITY; MICROBIOLOGY; MICROFLORA; MOUTH; PHYSIOLOGY; SYMBIOSIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; COMPUTER SIMULATION; DENTAL PLAQUE; FOOD HABITS; HUMANS; MICROBIAL VIABILITY; MICROBIOTA; MOUTH; ORAL HEALTH; SYMBIOSIS;

EID: 84928577409     PISSN: 00086568     EISSN: 1421976X     Source Type: Journal    
DOI: 10.1159/000377732     Document Type: Conference Paper

References (66)

1. Amer LS, Bishop BM, van Hoek ML: Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem Biophys Res Commun 2010; 396: 246-251.
2. American Dental Association Council of Scientific Affairs: Guidelines for acceptance of chemotherapeutic products for control of gingivitis. 2008.
3. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B: The intestinal microbiome in early life: health and disease. Front Immunol 2014; 5: 427.
4. Belkaid Y, Naik S: Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 2013; 14: 646-653.
5. Bishu S, Hernandez-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL: The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect Immun 2014; 82: 1173-1180.
6. Brading MG, Marsh PD: The oral environment: the challenge for antimicrobials in oral care products. Int Dent J 2003; 53: 353-362.
7. Bradshaw DJ, Marsh PD, Watson GK, Cummins D: The effects of triclosan and zinc citrate, alone and in combination, on a community of oral bacteria grown in vitro. J Dent Res 1993; 72: 25-30.
8. Canny GO, McCormick BA: Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 2008; 76: 3360-3373.
9. Chen H, Jiang W: Application of high-throughput sequencing in understanding human oral microbiome related with health and disease. Front Microbiol 2014; 5: 508.
10. Chino T, Santer DM, Giordano D, Chen C, Li C, Chen CH, Darveau RP, Clark EA: Effects of oral commensal and pathogenic bacteria on human dendritic cells. Oral Microbiol Immunol 2009; 24: 96-103.
11. Cho I, Blaser MJ: Applications of next-generation sequencing the human microbiome: At the interface of health and disease. Nat Rev Genet 2012; 13: 260-270.
12. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK: Host-bacterial symbiosis in health and disease. Adv Immunol 2010; 107: 243-274.
13. Christensen GJ, Bruggemann H: Bacterial skin commensals and their role as host guardians. Benef Microbes 2014; 5: 201-215.
14. Cogen AL, Nizet V, Gallo RL: Skin microbiota: A source of disease or defence? Br J Dermatol 2008; 158: 442-455.
15. Consortium THMP: Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
16. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE: The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 2008; 76: 4163-4175.
17. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA: The application of ecological theory toward an understanding of the human microbiome. Science 2012; 336: 1255-1262.
18. Crielaard W, Zaura E, Schuller AA, Huse SM, Montijn RC, Keijser BJ: Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med Genomics 2011; 4: 22.
19. Cummins D: Mechanisms of action of clinically proven anti-plaque agents; in Embery G, Rolla G (eds): Clinical and Biological Aspects of Dentifrices. Oxford, Oxford University Press, 1992, pp 205-228.
20. Dean SN, Bishop BM, van Hoek ML: Natural and synthetic cathelicidin peptides with antimicrobial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011; 11: 114.
21. Dougall HT, Smith L, Duncan C, Benjamin N: The effect of amoxycillin on salivary nitrite concentrations: An important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-462.
22. Duckworth RM: Pharmacokinetics in the oral cavity: fluoride and other active ingredients. Monogr Oral Sci 2013; 23: 125-139.
23. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C: Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 2012; 8: e1002606.
24. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, Oberholzer A: Molecular characterization of the acute inflammatory response to infections with Gramnegative versus Gram-positive bacteria. Infect Immun 2003; 71: 5803-5813.
25. Freire MO, van Dyke TE: Natural resolution of inflammation. Periodontol 2000 2013; 63: 149-164.
26. Govoni M, Jansson EA, Weitzberg E, Lundberg JO: The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008; 19: 333-337.
27. Hancock REW, Nijnik A, Philpott DJ: Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 2012; 10: 243-254.
28. Hasturk H, Kantarci A, van Dyke TE: Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012; 15: 160-176.
29. Head DA, Marsh PD, Devine DA: Non-lethal control of the cariogenic potential of an agent-based model for dental plaque. PLoS One 2014; 9:e105012.
30. Ivanov II, Honda K: Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012; 12: 496-508.
31. Kaci G, Goudercourt D, Dennin V, Pot B, Dore J, Ehrlich SD, Renault P, Blottiere HM, Daniel C, Delorme C: Anti-inflammatory properties of Streptococcus salivarius , a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol 2014; 80: 928-934.
32. Kai-Larsen Y, Luthje P, Chromek M, Peters V, Wang XD, Holm A, Kadas L, Hedlund KO, Johansson J, Chapman MR, Jacobson SH, Romling U, Agerberth B, Brauner A: Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 2010; 6:e1001010.
33. Kamada N, Nunez G: Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146: 1477-1488.
34. Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A: Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med 2013; 55: 93-100.
35. Marsh PD: Host defenses and microbial homeostasis: role of microbial interactions. J Dent Res 1989; 68: 1567-1575.
36. Marsh PD: Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res 1992; 71: 1431-1438.
37. Marsh PD: Are dental diseases examples of ecological catastrophes? Microbiology 2003; 149: 279-294.
38. Marsh PD: Controlling the oral biofilm with antimicrobials. J Dent 2010; 38(suppl 1):S11-S15.
39. Marsh PD: Contemporary perspective on plaque control. Br Dent J 2012; 212: 601-606.
40. Marsh PD, Head DA, Devine DA: Prospects of oral disease control in the future-an opinion. J Oral Microbiol 2014;6: 26176.
41. Marsh PD, Martin MV: Oral Microbiology, ed 5. Edinburgh, Churchill Livingstone, 2009.
42. McMahon L, Schwartz K, Yilmaz O, Brown E, Ryan LK, Diamond G: Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun 2011; 79: 2250-2256.
43. Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR: Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 2007; 148: 307-324.
44. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
45. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289: 1560-1563.
46. Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA, Hancock REW: Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008; 76: 4176-4182.
47. Petersson J, Carlstrom M, Schreiber O, Phillipson M, Christoffersson G, Jagare A, Roos S, Jansson EA, Persson AE, Lundberg JO, Holm L: Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med 2009; 46: 1068-1075.
48. Reffuveille F, de la Fuente-Nunez C, Mansour S, Hancock REW: A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother 2014; 58: 5363-5371.
49. Relman DA: The human microbiome: ecosystem resilience and health. Nutr Rev 2012; 70(suppl 1):S2-S9.
50. Sampaio-Maia B, Monteiro-Silva F: Acquisition and maturation of oral microbiome throughout childhood: An update. Dent Res J 2014; 11: 291-301.
51. Sanchez FR, Perrone M, Acevedo AM: Microbiological composition of dental plaque using Sprague Dawley rats as an experimental model (in Spanish). Acta Odontol Venez 1990; 28: 9-13.
52. Smith PM, Garrett WS: The gut microbiota and mucosal T cells. Front Microbiol 2011; 2: 111.
53. Srinivasan N: Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Innate Immun 2010; 16: 391-404.
54. Tagliabue A, Elli M: The role of gut microbiota in human obesity: recent findings and future perspectives. Nutr Metab Cardiovasc Dis 2013; 23: 160-168.
55. Takahashi N, Washio J: Metabolomic effects of xylitol and fluoride on plaque biofilm in vivo. J Dent Res 2011; 90: 1463-1468.
56. Ten Cate JM, Marsh PD: Procedures for establishing efficacy of antimicrobial agents for chemotherapeutic caries prevention. J Dent Res 1994; 73: 695-703.
57. Teughels W, Newman MG, Coucke W, Haffajee AD, Van Der Mei HC, Haake SK, Schepers E, Cassiman JJ, Van Eldere J, van Steenberghe D, Quirynen M: Guiding periodontal pocket recolonization: A proof of concept. J Dent Res 2007; 86: 1078-1082.
58. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
59. Van Dyke TE: The management of inflammation in periodontal disease. J Periodontol 2008; 79: 1601-1608.
60. Van Winkelhoff A, Boutaga K: Transmission of periodontal bacteria and models of infection. J Clin Periodontol 2005; 32: 16-27.
61. Wade WG: The oral microbiome in health and disease. Pharmacol Res 2013; 69: 137-143.
62. Wang Q, Zhang T: Review of mathematical models for biofilms. Solid State Commun 2010; 150: 1009-1020.
63. Wright CJ, Burns LH, Jack AA, Back CR, Dutton LC, Nobbs AH, Lamont RJ, Jenkinson HF: Microbial interactions in building of communities. Mol Oral Microbiol 2013; 28: 83-101.
64. Yeung ATY, Gellatly SL, Hancock REW: Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 2011; 68: 2161-2176.
65. Zaura E, Keijser BJ, Huse SM, Crielaard W: Defining the healthy 'core microbiome' of oral microbial communities. BMC Microbiol 2009; 9: 259.
66. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmur R, Harmsen HJ: Oral biofilm architecture on natural teeth. PLoS One 2010; 5:e9321.